Browsing Tag
NASDAQ: XOMA
1 post
Why did XOMA give shareholders two more weeks on the LAVA Therapeutics deal – and what happens next?
XOMA (NASDAQ: XOMA) extends its tender offer for LAVA Therapeutics (NASDAQ: LVTX) to Oct 17. Explore shareholder impact, CVR value, and deal prospects.